NCT00543374Phase 3Completed

Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease

Study sponsor: Mesoblast, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2009-07Actual
Enrollment · participants98Actual
Source updated2026-03-11Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.